| Literature DB >> 14983980 |
Abstract
DP-b99 is a derivative of the calcium chelator BAPTA that is under development as a neuroprotectant for the potential treatment of stroke, head trauma and neurological damage associated with coronary artery bypass graft. By March 2003, phase II clinical trials in acute stroke and traumatic brain injury were ongoing.Entities:
Mesh：
Substances：
Year: 2004 PMID： 14983980
Source DB: PubMed Journal: Curr Opin Investig Drugs ISSN： 1472-4472